Please Wait
Applying Filters...
menu
    • menu
    Allsino Pharmaceutical -PSE
    News
    Providing R&D, production of RSMs & API for global pharmaceutical

    14 Jun 2023

    // PRESS RELEASE

    Synthetic pharmaceutical R&D and manufacturing

    14 Jun 2023

    // PRESS RELESE

    Biocon urges gov to exempt cancer, rare-disease drugs from tax

    20 Jan 2025

    // REUTERS

    Data Compilation
    #PharmaFlow

    Allsino VB RM

    Contact Supplier

    Website

    PharmaVenue

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/NUY-WJrSlVU
    Menu

    Allsino Pharmaceutical Co. Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    INTERMEDIATES

    SERVICES

    Key Services KEY SERVICES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 21-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-1H-pyrazole

    02 24-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

    03 14-Methyl-7-H-pyrrolo[2,3-d]pyrimidine

    04 1tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-...

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      1029716-44-6
      Baricitinib
      Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
      Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
      Allsino Company Banner

      01

      1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-1H-pyrazole

      China
      PharmaVenue
      Not Confirmed
      arrow
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

      Allsino Pharmaceutical Co. Ltd

      1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-...

      CAS Number : 1029716-44-6

      End Use API : Baricitinib

      About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

      Allsino Company Banner

      Intermediate Web Link

      Market Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
        Contact Supplier Contact Supplier
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-...

        Intermediate Web Link

        Market Place

        1029716-44-6
        Ruxolitinib Phosphate
        Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
        Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
        Allsino Company Banner

        02

        1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-1H-pyrazole

        China
        PharmaVenue
        Not Confirmed
        arrow
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

        Allsino Pharmaceutical Co. Ltd

        1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-...

        CAS Number : 1029716-44-6

        End Use API : Ruxolitinib Phosphate

        About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

        Allsino Company Banner

        Intermediate Web Link

        Market Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

          Intermediate Web Link

          Market Place

          3680-69-1
          Tofacitinib Citrate
          Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
          Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
          Allsino Company Banner

          03

          4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

          China
          PharmaVenue
          Not Confirmed
          arrow
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

          Allsino Pharmaceutical Co. Ltd

          4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

          CAS Number : 3680-69-1

          End Use API : Tofacitinib Citrate

          About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

          Allsino Company Banner

          Intermediate Web Link

          Market Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
            Contact Supplier Contact Supplier
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

            Intermediate Web Link

            Market Place

            3680-69-1
            Ruxolitinib Phosphate
            Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
            Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
            Allsino Company Banner

            04

            4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

            China
            PharmaVenue
            Not Confirmed
            arrow
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

            Allsino Pharmaceutical Co. Ltd

            4-Chloro-7H-pyrrolo-[2,3-d]pyrimidine

            CAS Number : 3680-69-1

            End Use API : Ruxolitinib Phosphate

            About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

            Allsino Company Banner

            Intermediate Web Link

            Market Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
              Contact Supplier Contact Supplier
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              4-Methyl-7-H-pyrrolo[2,3-d]pyrimidine

              Intermediate Web Link

              Market Place

              945950-37-8
              Ruxolitinib Phosphate
              Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
              Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
              Allsino Company Banner

              05

              4-Methyl-7-H-pyrrolo[2,3-d]pyrimidine

              China
              PharmaVenue
              Not Confirmed
              arrow
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

              Allsino Pharmaceutical Co. Ltd

              4-Methyl-7-H-pyrrolo[2,3-d]pyrimidine

              CAS Number : 945950-37-8

              End Use API : Ruxolitinib Phosphate

              About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

              Allsino Company Banner

              Intermediate Web Link

              Market Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.
                Contact Supplier Contact Supplier
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate

                Intermediate Web Link

                Market Place

                1153949-11-1
                Baricitinib
                Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manu...
                Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².
                Allsino Company Banner

                06

                tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate

                China
                PharmaVenue
                Not Confirmed
                arrow
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothAllsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

                Allsino Pharmaceutical Co. Ltd

                tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate

                CAS Number : 1153949-11-1

                End Use API : Baricitinib

                About the Company : Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, G...

                Allsino Company Banner

                Intermediate Web Link

                Market Place